102 related articles for article (PubMed ID: 21783435)
1. Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.
Shiohira H; Yasui-Furukori N; Tateishi T; Uno T
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2465-70. PubMed ID: 21783435
[TBL] [Abstract][Full Text] [Related]
2. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
[TBL] [Abstract][Full Text] [Related]
3. Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid-liquid extraction.
González HM; Romero EM; Chavez Tde J; Peregrina AA; Quezada V; Hoyo-Vadillo C
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):459-65. PubMed ID: 12401374
[TBL] [Abstract][Full Text] [Related]
4. Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.
Uno T; Yasui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):309-14. PubMed ID: 15664363
[TBL] [Abstract][Full Text] [Related]
5. The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers.
Yamada S; Shiohira H; Yasui-Furukori N; Tateishi T; Akamine Y; Uno T
Eur J Clin Pharmacol; 2013 Jul; 69(7):1423-8. PubMed ID: 23435615
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel inhibits CYP2C19-dependent hydroxylation of omeprazole related to CYP2C19 genetic polymorphisms.
Chen BL; Chen Y; Tu JH; Li YL; Zhang W; Li Q; Fan L; Tan ZR; Hu DL; Wang D; Wang LS; Ouyang DS; Zhou HH
J Clin Pharmacol; 2009 May; 49(5):574-81. PubMed ID: 19398604
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.
Miura M; Tada H; Suzuki T
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 May; 804(2):389-95. PubMed ID: 15081934
[TBL] [Abstract][Full Text] [Related]
8. Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
Hofmann U; Schwab M; Treiber G; Klotz U
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):85-90. PubMed ID: 16338182
[TBL] [Abstract][Full Text] [Related]
9. Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole.
Fan L; Wang G; Wang LS; Chen Y; Zhang W; Huang YF; Huang RX; Hu DL; Wang D; Zhou HH
Acta Pharmacol Sin; 2007 Oct; 28(10):1685-92. PubMed ID: 17883958
[TBL] [Abstract][Full Text] [Related]
10. Analysis of omeprazole, midazolam and hydroxy-metabolites in plasma using liquid chromatography coupled to tandem mass spectrometry.
Frerichs VA; Zaranek C; Haas CE
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):71-80. PubMed ID: 16027049
[TBL] [Abstract][Full Text] [Related]
11. Stereospecific analysis of omeprazole in human plasma as a probe for CYP2C19 phenotype.
Kanazawa H; Okada A; Higaki M; Yokota H; Mashige F; Nakahara K
J Pharm Biomed Anal; 2003 Jan; 30(6):1817-24. PubMed ID: 12485723
[TBL] [Abstract][Full Text] [Related]
12. Hydroxylation of R(+)- and S(-)-omeprazole after racemic dosing are different among the CYP2C19 genotypes.
Shiohira H; Yasui-Furukori N; Yamada S; Tateishi T; Akamine Y; Uno T
Pharm Res; 2012 Aug; 29(8):2310-6. PubMed ID: 22549736
[TBL] [Abstract][Full Text] [Related]
13. Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.
Uno T; Yasui-Furukori N; Shimizu M; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):238-43. PubMed ID: 16087412
[TBL] [Abstract][Full Text] [Related]
14. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.
Miura M; Tada H; Satoh S; Habuchi T; Suzuki T
J Pharm Biomed Anal; 2006 May; 41(2):565-70. PubMed ID: 16442771
[TBL] [Abstract][Full Text] [Related]
15. Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes.
Uno T; Yasui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Clin Pharmacol; 2005 Jun; 45(6):690-4. PubMed ID: 15901751
[No Abstract] [Full Text] [Related]
16. Omeprazole treatment of Korean patients: effects on gastric pH and gastrin release in relation to CYP2C19 geno- and phenotypes.
Roh HK; Kim PS; Lee DH; Tybring G; Sagar M; Park CS; Seensalu R; Bertilsson L
Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):112-9. PubMed ID: 15447734
[TBL] [Abstract][Full Text] [Related]
17. Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.
Kearns GL; Leeder JS; Gaedigk A
Drug Metab Dispos; 2010 Jun; 38(6):894-7. PubMed ID: 20223877
[TBL] [Abstract][Full Text] [Related]
18. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
Kanazawa H; Okada A; Matsushima Y; Yokota H; Okubo S; Mashige F; Nakahara K
J Chromatogr A; 2002 Mar; 949(1-2):1-9. PubMed ID: 11999727
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping.
Abouir K; Samer C; Landry R; Varesio E; Daali Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jan; 1232():123962. PubMed ID: 38096743
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
Bharathi DV; Hotha KK; Jagadeesh B; Chatki PK; Thriveni K; Mullangi R; Naidu A
Biomed Chromatogr; 2009 Jul; 23(7):732-9. PubMed ID: 19360758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
